Change Preferences
|
Sign Out
Sign In
|
Register Now
TODAY'S NEWSPAPER
Subscribe
|
PostPoints
News
Nation
Investigations
Photos & Video
Discussions
World
Education
Entertainment
Corrections
Metro
Health
Columns & Blogs
Innovations
Advertising: Kaplan University online degree programs. Apply now!
Politics
Politics Home
House/Senate Votes
White House
Congress
Politics Blogs
Special Reports
Polls
The Fed Page
DC
|
MD
|
VA
Opinions
Opinions Home
Local Opinions
Toles Cartoons
Outlook
Telnaes Animations
Discussions
Business
Business and Policy
Local Business
Entrepreneurship
Economy Watch
Technology
Columns & Blogs
Global Economy
Personal Finance
On Leadership
Local
Metro News
District
Weather
Obituaries
The Extras
Education
Maryland
Traffic
Local Explorer
Local Business
Columns & Blogs
Virginia
Crime
Community Handbook
Yellow Pages
Sports
Redskins
Mystics/WNBA
Colleges
Columnists
Capitals/NHL
United/Soccer
High Schools
Blogs
Nationals/MLB
Wizards/NBA
Leagues & Sports
Wires
Arts & Living
Style
Entertainment News
Museums
Columns & Blogs
Comics
Pets
Food
Fashion & Beauty
KidsPost
Crosswords
Movies
Travel
Home & Garden
Post Magazine
Weddings
Television
Books
Theater & Dance
Horoscopes
Sudoku
Going Out Guide
Find Restaurants
Visitors Guide
Find Movies
Best Bets
Find Bars & Clubs
Go Out List
Find Local Events
Going Out Gurus
Jobs
Find a Job
Post a Job
Get Expert Advice
Employer Login
Cars
Buy a Car
Sell a Car
Experts & Advice
Dealer Directory
Used Car Specials
Coupons
Real Estate
Buy a Home
Sell a Home
Neighborhoods
Recent Home Sales
Tools and Calculators
Local Address
Rentals
Find a Rental
Rent Your Place
Classifieds
Legal Notices
Shopping
Pets
Trustee Sales
Deals & Discounts
More Classifieds
Death Notices
Used Stuff
Place an Ad
SEARCH:
washingtonpost.com
Web
|
Search Archives
washingtonpost.com
>
Technology
>
Washtech
Your Comments On...
CEO Says Stock Pressure Drove MedImmune Deal
David M. Mott was an investment banker before joining MedImmune on April Fools' Day 1992, and in his 15 years with the company -- he eventually became chief executive -- he has been a fierce advocate for its independence.
-
By Michael S. Rosenwald
Comments
E-Mail This Page
© 2007 The Washington Post Company
Featured Advertiser Links
Lawsuit: Hydroxycut Liver
,
Cochlear Implants
,
Zicam
,
Yaz
>>
Erin Brockovich
,
Lawyer: Mesothelioma
,
Asbestos
,
Lung Cancer
>>
Get your credit score range from Equifax 100% Free.
>>
Create Jobs. Help the Economy. Join the National Gateway.
>>
Russia Now: In-Depth Coverage of Russia News, Business, and More.
>>
CEO Says Stock Pressure Drove MedImmune Deal
David M. Mott was an investment banker before joining MedImmune on April Fools' Day 1992, and in his 15 years with the company -- he eventually became chief executive -- he has been a fierce advocate for its independence.-
By Michael S. Rosenwald